Review Article

Antibody-Drug Conjugates in the Management of Breast Cancer

Breast cancer remains a predominant contributor to global cancer-related morbidity and mortality among women, with its incidence steadily rising and presenting complex therapeutic challenges. Conventional treatment modalities, including chemotherapy, endocrine therapy, and molecularly targeted interventions, have demonstrated substantial clinical efficacy. The emergence of therapeutic resistance, systemic cytotoxicity, and metastatic progression…

Posted in: antibody-drug conjugates (ADCs) 2 breast cancer therapy 2 monoclonal antibodies 2 targeted drug delivery 2 tumor-associated antigens 2

Original Article

Associations of Source and Continuity of Private Health Insurance with Prevalence of Chronic Pain among US Adults

Objectives: Coverage by private insurance is associated with lower chronic pain prevalence, but the significance of different types of private coverage for the epidemiology of chronic pain is poorly understood. The primary outcome was pain prevalence. Among respondents with chronic pain, secondary outcomes included experiences of severe pain, high-impact pain,…

Posted in: antibody-drug conjugates (ADCs) 2 breast cancer therapy 2 Chronic pain 4 independent rounding 2 monoclonal antibodies 2
SMA Menu